Use of high-dose ganciclovir for a resistant cytomegalovirus infection due to UL97 mutation

Transplant Infectious Disease

Volumn 10, Issue 2, 2008, Pages 129-132

  West, P ^a   Schmiedeskamp, M ^a   Neeley, H ^a   Oberholzer, J ^a   Benedetti, E ^a   Kaplan, B ^a  

^a UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

Author keywords

Cytomegalovirus; Ganciclovir; Resistance; Transplant; UL97 mutation

Indexed keywords

CYTOMEGALOVIRUS ANTIBODY; GANCICLOVIR; LEFLUNOMIDE; LOPERAMIDE; METHYLPREDNISOLONE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISONE; RAPAMYCIN; TACROLIMUS; THYMOCYTE ANTIBODY; VALGANCICLOVIR;

ADULT; ANAMNESIS; ANTIVIRAL RESISTANCE; ARTICLE; CASE REPORT; CLINICAL FEATURE; CYTOMEGALOVIRUS INFECTION; DOSE RESPONSE; DRUG DOSE REDUCTION; DRUG MEGADOSE; DRUG WITHDRAWAL; DUODENUM BIOPSY; GENE MUTATION; HUMAN; HUMAN TISSUE; KIDNEY FAILURE; KIDNEY GRAFT REJECTION; KIDNEY TRANSPLANTATION; LABORATORY TEST; MALE; MORBIDITY; MORTALITY; NEPHROTOXICITY; PREVALENCE; PRIORITY JOURNAL; UNSPECIFIED SIDE EFFECT;

ANTIVIRAL AGENTS; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTIONS; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG RESISTANCE, VIRAL; GANCICLOVIR; HUMANS; KIDNEY TRANSPLANTATION; MALE; MIDDLE AGED; MUTATION; PHOSPHOTRANSFERASES (ALCOHOL GROUP ACCEPTOR); TREATMENT OUTCOME;

EID: 40849098571     PISSN: 13982273     EISSN: 13993062     Source Type: Journal    
DOI: 10.1111/j.1399-3062.2007.00249.x     Document Type: Article

References (7)

1. American Society of Transplantation, Infectious Disease Community of Practice. Cytomegalovirus. Am J Transplant 2004 4 : 51 58.
2. Paya CV, Razonable RR. Cytomegalovirus infection after organ transplantation. In : Bowden RA, Ljungman P, Paya CV, eds. Transplant Infections (2nd edn.). Philadelphia : Lippincott Williams and Wilkins, 2003 : 298 325.
3. McGavin JK, Goa KL. Ganciclovir: an update of its use in the prevention of cytomegalovirus infection and disease in transplant recipients. Drugs 2001 61 : 1153 1183.
4. Nogueira E, Ozaki KS, Tomiyama H, et al. The emergence of cytomegalovirus resistance to ganciclovir therapy in kidney transplant recipients. Int Immunopharmacol 2006 6 : 2031 2037.
5. Chou S, Guentzel S, Michels KR, Miner RC, Drew WL. Frequency of UL97 phosphotransferase mutations related to ganciclovir resistance in clinical cytomegalovirus isolates. J Infect Dis 1995 172 : 239 242.
6. Erice A. Resistance of human cytomegalovirus to antiviral drugs. Clin Microbiol Rev 1999 12 : 286 297.
7. Chou S, Van Wechel LC, Lichy HM, Marousek GI. Phenotyping of cytomegalovirus drug resistance mutations by using recombinant viruses incorporating a reporter gene. Antimicrob Agents Chemother 2005 49 : 2710 2715.